Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO) | MicrobiomeTrials← Back to trialsNCT06101667
Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)
CompletedNAINTERVENTIONAL
Trial Details
Start: 2023-11-16Est. Completion: 2026-02-25
Enrollment target: 224 participants Locations- Beijing Tiantan Hospital, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Acute Ischemic Stroke AIS
This is a Phase IIa clinical trial with a three-arm design that utilizes randomization, double-blinding, and placebo con…
Beijing, ChinaEst. completion May 31, 2027
Acute Ischemic Stroke (AIS)
Acute ischemic stroke caused by blockage of a large artery in the brain is one of the leading causes of death and long-t…
Suzhou, ChinaEst. completion May 31, 2028
ENROLLING_BY_INVITATION
Ischaemic StrokeCarotid EndarterectomyCarotid Stenting
The objective of this clinical trial is to compare immediate and long-term results of carotid endarterectomy and carotid…
Moscow, RussiaCompleted May 21, 2027